Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - gliclazidum - compresse a rilascio modificato - gliclazidum 60 mg, excipiens pro compresso. - il diabete orale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - perindoprilum, amlodipinum, indapamidum - compressa rivestita con film - perindoprilum ut perindoprilum argininum 5 mg, amlodipinum 5 mg ut amlodipini besilas, indapamidum 1,25 mg, excipiens pro compresso obducto. - alta pressione sanguigna - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - perindoprilum, amlodipinum, indapamidum - compressa rivestita con film - perindoprilum ut perindoprilum argininum 5 mg, amlodipinum 10 mg ut amlodipini besilas, indapamidum 1,25 mg, excipiens pro compresso obducto. - alta pressione sanguigna - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - perindoprilum, amlodipinum, indapamidum - compressa rivestita con film - perindoprilum ut perindoprilum argininum 10 mg, amlodipinum 5 mg ut amlodipini besilas, indapamidum 2.5 mg, excipiens pro compresso obducto. - alta pressione sanguigna - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - perindoprilum, amlodipinum, indapamidum - compressa rivestita con film - perindoprilum ut perindoprilum argininum 10 mg, amlodipinum 10 mg ut amlodipini besilas, indapamidum 2.5 mg, excipiens pro compresso obducto. - alta pressione sanguigna - synthetika

European Union - Italian - EMA (European Medicines Agency)

les laboratoires servier - trifluridina, tipiracil hydrochloride - neoplasie colorettali - agenti antineoplastici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - diosminum, hesperidinum - compresse rivestite con film - diosminum 450 mg, flavonoidea corresp. hesperidinum 50 mg, carboxymethylamylum natricum a, cellulosum microcristallinum, gelatina, magnesii stearas, talcum, pellicule: glycerolum, natrii laurilsulfas, hypromellosum, magnesii stearas, e 172 (rubrum), macrogolum 6000, e 171, e 172 (flavum), pro compresso obducto corresp. natrium max. 1.14 mg. - l'insufficienza venosa e la malattia emorroidaria - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - indapamidum - compresse di ritardo - indapamidum 1,5 mg, excipiens pro compresso obducto. - antihypertenseur - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - gliclazidum - compresse a rilascio modificato - gliclazidum 30 mg, excipiens pro compresso. - il diabete orale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - gliclazidum - compresse a rilascio modificato - gliclazidum 60 mg, excipiens pro compresso. - il diabete orale - synthetika